 Mass High Tech | Zalicus slumps after ending Synavive development Businessweek THE BIG PICTURE: The main ingredients of Synavive are prednisolone, a synthetic steroid that is used to fight inflammation and other conditions, and dipyramidamole, which reduces the risk of blood clots. Zalicus said Synavive did not have a significant ... "Better Than Nothing" Doesn't Cut It for Zalicus Zalicus To Halt Clinical Development Of Synavive Zalicus stock plummets 33% after halting Synavive trial |
